|
|||
|
Multiple Sclerosis Info
|
Monday, December 31
by
multiplesclerosis
on Mon 31 Dec 2007 10:09 AM CST
Five-year cardiac and haematological data from a large cohort of multiple sclerosis (MS) patients show that mitoxantrone is generally well tolerated and safe. The results on mitoxantrone, which is routinely used in more »
by
multiplesclerosis
on Mon 31 Dec 2007 09:51 AM CST
NICE Recommends TYSABRI® for Use in Highly Active Relapsing Remitting Multiple Sclerosis Final Guidance Issued on First MS Treatment Recommended by NICE MAIDENHEAD, ... more »
by
multiplesclerosis
on Mon 31 Dec 2007 09:46 AM CST
"Immune Response to Influenza Vaccine is Maintained in MS Patients Treated With Rebif (interferon beta-1a)" November 10, 2005 – Data presented at: XVIIIth World Congress of Neurology in ... more »
by
multiplesclerosis
on Mon 31 Dec 2007 09:31 AM CST
Long-term Use of Glatiramer Acetate (Copaxone) for Multiple Sclerosis Appears Safe and Efficacious: Presented at ECTRIMS By Bruce Sylvester THESSALONIKI, GREECE – September 30, 2005 – Patients with relapsing-remitting multiple ... more »
by
multiplesclerosis
on Mon 31 Dec 2007 09:07 AM CST
BENEFIT Study Shows Interferon Beta-1b Delays Development of MS in Patients with First Clinical Signs of Disease BASEL, SWITZERLAND -- October 14, 2005 – Interferon beta-1b 250 mcg* ... more » Thursday, December 13
by
multiplesclerosis
on Thu 13 Dec 2007 09:24 AM CST
U.S. FDA Approves Betaseron(R) (Interferon beta-1b) for Use After the First Event Suggestive of Multiple Sclerosis Early Treatment With Betaseron Significantly Delayed the Time ... more »
by
multiplesclerosis
on Thu 13 Dec 2007 09:23 AM CST
Using interferon beta-1b (Betaseron) therapy in patients with the first clinical symptoms of MS (MS) significantly postpones the development of more »
by
multiplesclerosis
on Thu 13 Dec 2007 04:09 AM CST
Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression WAYNE, N.J., Wednesday, December 12
by
multiplesclerosis
on Wed 12 Dec 2007 08:07 PM CST
Glatiramer Acetate Injections Reduced Relapses by 75% in Both Treatment-Naïve Multiple Sclerosis Patients and Those Failing Interferon Beta-1bMore than 80% of All Patients Experienced an ... more »
by
multiplesclerosis
on Wed 12 Dec 2007 08:04 PM CST
Join Shared Solutions® Become a Member in Canada Shared Solutions® is a free comprehensive multiple sclerosis (MS) patient support program. When you ... more » Sunday, December 9
by
multiplesclerosis
on Sun 09 Dec 2007 09:46 AM CST
Biogen Idec Launches New AVONEX(R) Nurse Services Program CAMBRIDGE, Mass.— Biogen Idec announced today the national launch of the new |
||